Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 367 results for "cadila pharmaceutical"

Cadila, Depomed Inc settle patent dispute
Business Standard India

CADILA HEALTHCARE : ZYDUS -Cadila Healthcare Limited Announces...

Release date- 15042014 - Cadila Healthcare Limited , a global pharmaceuticals company, and Zydus Pharmaceuticals (USA), Inc. , a leading generic pharmaceutical company in the United States , today announced that they have entered into a settlement ... 4 Traders, 2 days ago
Cadila, Depomed settle case on gapapentin Times of India, 3 days ago
[x]  

13 images for cadila pharmaceutical

Rediff.com, 2 weeks ago
Times of India, 2 months ago
Financial Express, 3 months ago
Oneindia, 1 month ago
Bio Spectrum Asia, 3 months ago
Rediff.com, 2 months ago
Financial Express, 4 months ago
New Indian Express, 4 months ago
Rediff.com, 4 months ago
Sify, 4 months ago

Pharma duo settle patent row in US

(PTI): Cadila Healthcare and Zydus Pharmaceuticals today said they had entered into a settlement agreement with Depomed Inc in a patent infringement row. The case is related to Depomeds neuropathic pain relieving drug Gralise. Cadila Healthcare and Zydus ...
 The Telegraph3 days ago Cadila Healthcare, Zydus Pharmaceuticals to settle patent infringement case with Depomed Inc  Economic Times3 days ago Cadila, Zydus to settle patent infringement case with Depomed  Business Standard3 days ago
[x]  
Moneycontrol.com

Select pharma shares on a roll, Wockhardt zooms 20%

Wockhardt, Strides Arcolab and Ranbaxy Laboratories have rallied between 10-20%, while Aurobindo Pharma, Cadila Healthcare, Cipla, Biocon, Lupin and Divi's Laboratories are trading higher in the range of 2-6% on the BSE. The BSE pharmaceutical ...
 Smart Investor2 weeks ago Aurobindo up 6%, Lupin hits record high post Nomura report  Moneycontrol.com1 month ago
Business Standard

Panel rejects clinical trial applications by leading drug makers

Proposals from leading pharmaceutical companies such as Novo Nordisk, Cadila Pharmaceuticals, Wockhardt, Novartis, Roche and Reliance Life Sciences for conducting clinical trials were recently rejected by a regulatory committee, formed following the Supreme ...
 Business Standard2 weeks ago Panel rejects clinical trial plea by some drug makers  Smart Investor2 weeks ago
Business Standard

Zydus Cadila get USFDA nod for Clonidine Hcl injections

Pharmaceuticals firm Zydus Cadila today said it has received final approval from US health regulator to market Clonidine Hcl injections used in treating severe pain in cancer patients. The approval from the US Food and Drug Administration ( USFDA) is for ...
 Business Standard1 month ago Zydus Cadila's Moraiya facility in for USFDA inspection  Smart Investor1 month ago
[x]  

Cadila gains on USFDA final nod for Clonidine Hcl Injection

Cadila Healthcare , one of the leading pharmaceutical companies, gained on Tuesday after it received the final approval from the USFDA to market Clonidine Hcl Injection 0.1 and 0.5 mg/ml, 10 ml. Clonidine hydrochloride injection is a centrally-acting ...
 Myiris1 month ago

Dr. Rajiv I. Modi, CMD, Cadila Pharmaceuticals

is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, Gujarat. Over the last six decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries ...
 India Infoline1 month ago

Shire Faces Patent Suit Revival Over Lialda Colitis Drug

Shire Plc (SHP) 's patent-infringement lawsuit against Cadila Healthcare Ltd. and Zydus Pharmaceuticals Inc. over the colitis drug Lialda was reopened, according to court filings. A federal judge in Wilmington, Delaware , yesterday ordered the ...
 Bloomberg1 month ago Shire Faces Revival of Patent Suit Over Lialda Colitis Drug (1)  BusinessWeek1 month ago

4 - Cadila Pharmaceuticals Ltd (0001461239) (Reporting)

Document Format Files Seq Description Document Type Size 1 FORM 4 SUBMISSION doc4.html 4 1 FORM 4 SUBMISSION doc4.xml 4 9606 2 EX-99 DOCUMENT attachment1.htm EX-99 724 Complete submission text file
 SEC Filings4 weeks ago Cadila Pharmaceuticals Ltd (0001461239)  SEC4 weeks ago
4 Traders

Novavax major shareholder Sells $14,850,000 in Stock (NVAX)

Novavax (NASDAQ:NVAX) major shareholder Pharmaceuticals Ltd Cadila sold 3,000,000 shares of Novavax stock on the open market in a transaction dated Friday, March 21st. The stock was sold at an average price of $4.95, for a total transaction of ...
 American Banking News4 weeks ago NOVAVAX : NVAX) Plunges on Insider Sale, Continues Downtrend in Devastating Month of March  4 Traders3 weeks ago Novavax (NVAX) Plunges on Insider Sale, Continues Downtrend in Devastating Month of March  Equities.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less